Literature DB >> 23537301

apoB-independent enzyme immunoassay for lipoprotein(a) by capture on immobilized lectin (jacalin).

Anuradha Sreekumar1, Geetha Mandagini, Sabarinath P Subramanian, Appukuttan P Sankunni.   

Abstract

Enzyme immunoassay for lipoprotein(a) [Lp(a)] using antibodies to both apoB and apo(a) subunits (a-B assay) is shown to be affected by differential masking of apoB by apo(a) and the presence of LDL-Lp(a) adducts. An apoB-independent immunoassay by capturing Lp(a) through its O-glycans on microplate-coated lectin jacalin and quantitation using peroxidase-labeled anti-apo(a) (J-a assay) is described. J-a assay response is linear, more than twice as sensitive as a-B assay, and is suppressed only 18 ± 5% by non-Lp(a) O-glycan-containing proteins of serum. Wide variations in IgA did not significantly affect Lp(a) binding to jacalin (CV = 6.4%).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537301     DOI: 10.1080/15321819.2012.699493

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  6 in total

1.  Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein(a).

Authors:  Jessy John; Vasantha Kalaivani; Mandagini Geetha; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2019-08

2.  Immunopathology of desialylation: human plasma lipoprotein(a) and circulating anti-carbohydrate antibodies form immune complexes that recognize host cells.

Authors:  P S Sabarinath; P S Appukuttan
Journal:  Mol Cell Biochem       Date:  2015-01-30       Impact factor: 3.396

3.  Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells.

Authors:  Vasantha Kalaivani; Padinjaradath Sankunni Appukuttan
Journal:  Lipids       Date:  2014-08-21       Impact factor: 1.880

4.  Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.

Authors:  Binu Sheela; Genu George; Geetha Mandagini; Padinjaradath S Appukuttan
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

5.  Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Authors:  Jessy John; Kurian Cherian; Thomas Abraham; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

6.  Plasma anti-α-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a).

Authors:  M Geetha; V Kalaivani; P S Sabarinath; P S Appukuttan
Journal:  Glycoconj J       Date:  2014-04-11       Impact factor: 2.916

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.